According to a recent study, 44% of people with chronic conditions who responded to a population-based survey experienced medication-related burden (MRB). The burden was most common among people with diabetes, heart disease, rheumatic disease or […]
An innovative new pill could soon offer a new and affordable weight management treatment, following a successful clinical trial involving University of Bristol researchers. The results are published in a paper titled “A randomized, double-blind, […]
The Trump administration announced that Boston-based drugmaker EMD Serono will lower the price of one of its leading fertility drugs as part of a push to make in vitro fertilization (IVF) more affordable.This article was […]
We often hear the phrase, “You are what you eat.” But what if it also applied to your children—even before they’re born? Research from the Texas A&M University Health Science Center (Texas A&M Health) suggests […]
Family caregivers for people with dementia report emotional strain from witnessing personality changes, physical exhaustion from providing intensive supervision, social isolation, and financial hardship. To receive counseling and information, they can call the Alzheimer’s Association’s […]
California will start selling low-cost insulin on Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make lifesaving medications more affordable for folks with diabetes.This article was originally published on MedicalXpress.com
About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly to available therapies. Yet they too may eventually see improvement, if not total relief, from their […]
When ultra-runners lace up for races that stretch hundreds of miles and days, they’re not merely testing their mental grit and muscle strength—they’re probing the limits of human biology. Reporting in Current Biology, researchers found […]
Current NHS policies designed to improve care for people taking multiple medicines may not be effective, according to new research.This article was originally published on MedicalXpress.com
The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant non-small cell lung cancer (NSCLC), according to data from a trial led by researchers at The University of […]
© 2025 SimplyWell.ca